Home
BROOKS.NS

Brooks Laboratories Limited

NSEHealthcare
₹77.60
+2.23%+₹1.69 today
₹0.00₹0.00
Ask Warren
Open
₹0.00
Prev close
₹75.91
Day range
₹0 – ₹0
52W range
₹36.3 – ₹163.9
Volume
54.0K
Avg vol (20D)
2.7L
Mkt cap
₹227.44Cr
P/E TTM
9.2×

Trade Brooks Laboratories Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Company Metrics

Revenue (ttm)₹85.74 Cr
Net Income (ttm)₹0.00
Shares Out2.95 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date

Trading Metrics

Beta1.10

About BROOKS.NS

Brooks Laboratories Limited provides contract development and manufacturing services for pharmaceutical companies in India and internationally. The company's product portfolio includes liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; B-Lactam and cephalosporin tablets, dry powder syrups, and injections; general, liquid, and dry powder injections; formulations for antibiotics, pain management, and controlled drugs; and oncology products and hormonal injections, etc. It also provides regulatory compliance, custom branding and packaging, scalable production, and end-to-end support services. The company serves government health programs and public sector institutions, hospitals and medical colleges, defense and railways, corporate healthcare, and NGOs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan Nigeria, Lebanon, Mauritius, Sudan, Madagascar, DR Congo, Mozambique, LATAM, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees0
Stock ExchangeNSE
Ticker SymbolBROOKS.NS
BROOKS.NS · NSE
Financial Performance

In 2026, Brooks Laboratories Limited's revenue was ₹85.74 Cr, an decrease of +13.30% compared to the previous year. Earnings were ₹0.00, an decrease of 0.00%.

Revenue (2026)
₹85.74 Cr
-13.30% YoY
Earnings (2026)
₹0.00
0.00% YoY
Year-over-Year Growth
Revenue
-13.30%
Earnings
0.00%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.